期刊文献+

TP与PVB两种同步放化疗方案在维吾尔族中晚期宫颈癌的近期疗效比较 被引量:18

Clinical analysis of two different chemotherapy regimens for concurrent chemoradiotherapy in advanced cervical cancer for Uyghur women
下载PDF
导出
摘要 目的:比较分析中晚期宫颈癌同步放化疗TP与PVB两种化疗方案的近期疗效及安全性。方法:回顾性分析新疆医科大学附属肿瘤医院2012年1月至2014年1月收治的接受同步放化疗的187例新疆维吾尔族宫颈癌中晚期患者(Ⅱb-Ⅳa期),根据化疗方案不同分为两组:TP方案组104例、PVB方案组83例。治疗结束4周后进行疗效评价,比较两组的近期疗效和毒副反应。结果:近期疗效:两种治疗方案对于鳞癌的有效率分别为85.9%及73.5%,差异无统计学意义(P〉0.05),对于非鳞癌(腺癌及腺鳞癌)的有效率分别为75.7%及40%,差异有统计学意义(P〈0.05)。毒副反应:骨髓抑制、周围神经毒性、胃肠道不良反应比较有统计学差异(P〈0.05)。肝肾功能损害、血细胞减少及放射性损伤无统计学意义(P〉0.05)。结论:对于宫颈鳞癌,两种同步放化疗近期疗效相当,对于非鳞癌,TP方案优于PVB方案。TP方案的骨髓抑制及神经毒性反应发生率明显高于PVB方案、胃肠道反应发生率则低于PVB方案。 Objective To compare theshort-term efficacy and safety between TP and PVB schemechemoradiation for advanced cervical cancer. Methods Between January 2012 and January 2014, 187 Xinjianguygur patients with advanced cervical cancer (stage I1 b to 1Va) who received concurrent chemoradiotherapy inXinjiang medical university affiliated tumor hospital were analyzed. All cases were divided into two groupsreceiving radiotherapy concomitant (n = 104), PVB group (n = 83). Theshort-term efficacy and toxicity wasevaluated four weeks aftertreatment. Results For squamous cell carcinomas, the response rates were 85.9% and73.5% in TP and PVB group respectively (P 〉 0.05). For Non-squamous cell carcinomas (adenocarcinoma andadenosquamous), the response rates were 75.7% and 40% in TP and PVB group respectively (P 〈 0.05). B onemarrow suppression, neurotoxicity, gastrointestinal reactionwere significant different between two groups (P 〈0.05). Liver and kidney functiondisorder, blood cellsreduction, and radiation damagewere not significantlydifferent (P 〉 0.05). Conclusions For cervical squamous cell carcinomas, theshort-term efficacy of twochemotherapy regimens is similar while forNon-squamous cell carcinomas, TP regimengroup is superior toBonemarrow suppression and neurotoxicity in TP regimengroup is significantly higher than PVB group (P 〈 0.05),while gastrointestinal adverse reaction lower than PVBgroup.
出处 《实用医学杂志》 CAS 北大核心 2014年第18期2928-2930,共3页 The Journal of Practical Medicine
基金 新疆维吾尔自治区自然科学基金(编号:2013211A061) 新疆医科大学科研创新基金资助项目(编号:XJC2013125)
关键词 宫颈肿瘤 放化疗 维吾尔族 中晚期 肿瘤治疗方案 Chemoradiation Cervical tumor Uygur Advanced Antineoplastic protocols
  • 相关文献

参考文献7

二级参考文献45

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2程晓东,吕卫国,叶枫,陈怀增,谢幸.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006,41(2):95-98. 被引量:66
  • 3成慧君,陆寓非,王雯.放化疗治疗中晚期宫颈癌[J].医药论坛杂志,2006,27(2):32-34. 被引量:7
  • 4彭杰文,梁汉霖,肖剑军,张朝珍.多西紫杉醇联合奈达铂治疗晚期宫颈癌的疗效观察[J].中国肿瘤临床与康复,2006,13(2):114-116. 被引量:17
  • 5谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:573.
  • 6焦桂青,杨晓峰.顺铂联合放疗治疗晚期子宫颈癌的临床分析[J].河北北方学院学报(医学版),2007,24(5):23-25. 被引量:5
  • 7Chemoradiotherapy for Cervical Cancer Meta Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta analysis of individual patient data from 18 randomized trials [J]. J Clin Oncol, 2008,26(35):5802-5812.
  • 8康婷,刘敏.TP方案联合放疗同步与序贯治疗中晚期宫颈癌的对比研究[J].临床研究,2011,11(8):50-51.
  • 9Ohno T, Kato S, Wakatsuki M, et al. incidence and temporal pattern of anorexia, diarrhea, weight loss, and leuko-penia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: therapy alone [J]. Gynecol Oncol comparison with radiation 2006,103 ( 1 ) : 94-99.
  • 10King M, MeConkey C, Lati ef T N, et al. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with as sessment of acute and late side effects [J]. Clin Oncol (R Col 1 Radiol), 2006,18( 1 ) : 38-45.

共引文献110

同被引文献166

  • 1陈涛利,卞翠翠,杨雷,刘子玲.早期高危宫颈癌患者术后不同治疗方案的临床疗效[J].中国老年学杂志,2015,35(1):55-57. 被引量:25
  • 2陈玲英,夏雅仙.高龄子宫内膜癌患者的综合治疗[J].中国老年学杂志,2015,35(2):393-394. 被引量:9
  • 3陈春林,谭道彩,梁立治.动、静脉灌注化疗子宫颈癌组织药物浓度的比较[J].中华妇产科杂志,1995,30(5):298-298. 被引量:172
  • 4党之俊,温树伟,畅俊平,苑天文.双侧髂内动脉灌注化疗治疗晚期宫颈癌临床分析[J].山西医药杂志,2006,35(5):457-458. 被引量:9
  • 5谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 6Lin CY,Tsai PH,Kandaswami CC,et al.Matrix mcta|loprotcinas-9 cooperates with transeript ion factor snail to induce epifllelial-mesenchymal transition[J].Cancer Sci,2011,102(4):815-827.
  • 7Ma K, Yang YH, Yang X, et al. Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-lib cervical cancer[J]. Beijing Da Xue Xue Bao, 2013, 45(6): 910-915.
  • 8Saito I, Kitagawa R, Fukuda H, et al. A phase III trial ofpa- clitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gyneco- logic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)[J]. Jpn J Clin Oncol, 2010, 40(1): 90- 93.
  • 9Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, ran- domized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cispl- atin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamouscell cervical carcinoma: the Snap-02 Italian Collaborative Study[J]. Ann Oncol, 2009, 20(4): 660-665.
  • 10Huang L, Liao LM, Liu AW, et al. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients[J]. BMC Cancer, 2014, 14: 140.

引证文献18

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部